The global dermatoscope market size was valued at USD 816.0 million in 2022. It is likely to witness lucrative expansion at a compound annual growth rate (CAGR) of 12.1% from 2023 to 2030. Increasing the prevalence of skin cancer is one of the primary factors driving the market. The American Academy of Dermatology (AAD) estimated that one in three Americans visit dermatologists and one in four are affected by skin disease every year. Hence, owing to a strong need to treat these conditions as well as minimize deaths caused by them, there is a high demand for sophisticated diagnostic techniques for chronic skin disorders. The esthetics industry is anticipated to witness a significant setback due to the COVID-19 pandemic.
According to Worldometer, as of October 2021, nearly 240 million coronavirus cases and around 4.8 million deaths due to the pandemic were reported across the globe. Since the majority of cosmetic products are not a medical necessity, lockdowns in several countries led to the closure of several beauty salons & med spas, dermatology clinics, and retail stores Government officials & hospital administrators across the globe urged healthcare professionals to cancel non-emergency appointments. This has resulted in postponement in the appointment and treatment of dermatoscopy procedures. With the ease of lockdown and restrictions during the third quarter of 2020, the market started witnessing significant growth.
Widespread awareness about skin cancer has led to high growth in the demand for dermatology-related diagnostics. Several awareness programs are being implemented to raise awareness about skin cancer's adverse effects. For instance, The Cancer Council Australia and the Australasian College of Dermatologists collaborate every year for National Skin Cancer Action Week. Such initiatives are expected to spur the growth of the market during the forecast period.
Over the past few years, there has been an increase in the introduction of technologically advanced products, which has led to the wide availability of different diagnostic devices for the detection of skin disorders. Healthcare professionals are using these devices to diagnose various skin diseases, which have proved to be highly effective and productive as compared to conventional diagnostic methods.
On the other hand, rapid technological advancements are leading to a spike in the prices of dermatoscopes, which is making them less affordable for people in developing regions. This is, thereby, anticipated to hamper the growth of the market. Nevertheless, a growing inclination towards dermatology to enhance aesthetic appearance is projected to stoke the growth of the market during the forecast period.
Contact dermatoscopes held the largest share of 37.3% in the market in 2022. Many of these devices are available, such as those with LED or halogen bulbs, optical lenses, and power sources that include rechargeable batteries.
Hybrid dermatoscopes are poised to exhibit lucrative growth in the forecast period. These novel medical devices possess qualities of contact as well as noncontact dermatoscopes. They also combine polarized and non-polarized modes for purpose of imaging. The Dermlite DL200 developed by 3Gen Company is a hybrid dermatoscope that combines non-polarized and polarized illumination for enhanced visualization of vascular structures and pigment.
In 2022, noncontact dermatoscopes held a significant share of the market. These instruments are new-age medical devices that exhibit increased efficiency and effectiveness. They aid in the early detection of skin melanoma and other lesions owing to which their adoption is rising.
Based on technology, LED dominated the dermatoscopes market in 2022 with 42.4% shares. It is also anticipated to exhibit the fastest growth in the forecast period. This technology is being increasingly used as LEDs produce less heat during illumination and prevent accidental fatalities. The illumination offered by these bulbs is also brighter than xenon and halogen bulbs.
Xenon technology and halogen lights are likely to account for relatively smaller shares in the market throughout the forecast period. Halogens produce a large quantity of heat, which can cause fatalities in medical settings where they are used. Similarly, xenon lights have several disadvantages.
Ultraviolet technology is expected to witness a lucrative CAGR during the forecast period owing to its introduction as a novel technology in the field of dermatoscopy. Lumio UV, manufactured by 3Gen, helps capture clinical images quickly and easily in the workplace with high-resolution image quality and ultraviolet light.
Based on modality, handheld devices dominated the market in 2022 with 51.8% shares owing to the convenient usage of these products. Enhanced visualization offered by them allows dermatologists to understand various conditions better. In contrast to trolley-mounted dermatoscopes, these instruments are lightweight and offer an enhanced viewing experience, owing to which their adoption is increasing.
The growth of the trolley-mounted instruments segment is estimated to be limited by their high price and portability. However, they are useful for mapping out and monitoring several skin diseases and lesions. These devices are designed to provide images of the entire body and capture the entire skin surface in a few clicks.
Headband dermatoscopes are anticipated to exhibit a significant CAGR of 12.2% in the forecast period owing to the novel technology associated with these devices. These devices are worn by dermatologists on their heads to illuminate lesions on a patient’s skin.
Dermatology clinics represented the leading share of 56.4% in the market in terms of revenue in 2022. Based on end-use, the market is bifurcated into dermatology clinics and hospitals. The increasing prevalence of skin cancer and melanoma is boosting the number of patients who visit dermatology clinics for treatment and care. The availability of sophisticated and technologically advanced medical equipment at dermatology clinics provides patients with quick and rapid diagnosis, which, in turn, provides the better treatment.
Hospitals held a significant share in 2022 owing to the high risk of skin cancer. Patients diagnosed with cancer are likelier to visit hospitals for advanced diagnosis and treatment. Also, the easy availability of specialized doctors in hospitals aids in convenient cancer diagnosis and treatment.
In 2022, North America accounted for the largest revenue of 37.0%. The high prevalence of skin diseases, the presence of advanced healthcare infrastructure, medical device manufacturers, and economic development are some of the key growth stimulants for the regional market.
Europe held a sizeable share of the market in 2022 owing to the high adoption of technologically advanced devices for the diagnosis of skin cancer, inflammatory dermatoses, and lesions, especially in Germany. Increasing the incidence of skin-related diseases in the U.K. is contributing to the growth of the regional market.
Asia Pacific is projected to register the highest CAGR of 13.3% during the forecast period owing to the high prevalence of basal cell carcinoma, melanoma, squamous cell carcinoma, actinic keratosis, inflammatory dermatoses, and non-pigmented skin lesions in the region.
Key manufacturers are continuously adopting strategic initiatives such as mergers and acquisitions, new product development, and geographic expansion. For instance, in December 2021, Canfield Scientific, Inc. announced the acquisition of Medici Medical s.r.l. The acquisition is likely to expand Canfield’s sales and service operations. Some of the prominent players in the dermatoscope market include:
Canfield Scientific, Inc.
Optilia Instruments AB
HEINE Optotechnik GmbH & Co. KG
Caliber Imaging & Diagnostics, Inc.
ILLUCO Corporation Ltd.
Market size value in 2023
USD 0.9 billion
Revenue forecast in 2030
USD 2.0 billion
CAGR of 12.1% from 2023 to 2030
Base year for estimation
2018 - 2021
2023 - 2030
Revenue in USD billion and CAGR from 2023 to 2030
Revenue forecast, competitive landscape, growth factors, and trends
Product, technology, modality, end-use, region
North America; Europe; Asia Pacific; Latin America; MEA
U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway Japan; India; China; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
Canfield Scientific, Inc.; 3Gen; FotoFinder Systems, Inc.; Optilia; HEINE Optotechnik GmbH & Co. KG; Caliber Imaging & Diagnostics, Inc.; Firefly Global; ILLUCO Corporation Ltd.; Welch Allyn; Bio-Therapeutic, Inc.
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional, and segment scope.
Pricing and purchase options
Avail customized purchase options to meet your exact research needs. Explore purchase options
This report forecasts revenue growth at global, regional, and country levels, and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global dermatoscope market report based on product, technology, modality, end-use, and region:
Product Outlook (Revenue, USD Million, 2018 - 2030)
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Modality Outlook (Revenue, USD Million, 2018 - 2030)
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Regional Outlook (Revenue, USD Million, 2018 - 2030)
b. The global dermatoscopes market size was estimated at USD 816.0 million in 2022 and is expected to reach USD 0.9 billion in 2023.
b. The global dermatoscopes market is expected to grow at a compound annual growth rate of 12.1% from 2023 to 2030 to reach USD 2.0 billion by 2030.
b. North America dominated the dermatoscopes market with a share of 37.0% in 2022. This is attributable to rising healthcare awareness coupled with advanced healthcare infrastructure, medical device manufacturers, and economic development.
b. Some key players operating in the dermatoscopes market include Canfield Scientific, Inc.; 3Gen; FotoFinder Systems, Inc.; Optilia; HEINE Optotechnik GmbH & Co. KG; Caliber Imaging & Diagnostics, Inc.; Firefly Global; ILLUCO Corporation Ltd.; Welch Allyn; and Bio-Therapeutic, Inc.
b. Key factors that are driving the market growth include rising prevalence of skin cancer and other skin diseases, awareness about those diseases, and availability of technologically advanced products.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now
"The quality of research they have done for us has been excellent."